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The production of semisynthetic human insulin for
therapeutic purposes is of considerable importance. During
trypsin-catalysed transformation of pig insulin into an ester
of insulin of human sequence, the alanyl residue at position
B30 is removed and replaced with an esterified residue of
threonine. We have carried out this transformation in a
medium enriched in 18OH2 and studied the product by MS.
In contrast to a previous report, we find that incorporation
of label into the B 2 9 -B peptide bond occurs during
the transformation with threonine methyl ester in aqueous
A^iV-dimcthylacetamide. Quantitative data are presented and
the implications of these findings are discussed.
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Introduction
The production of insulin of human sequence on an industrial
scale is one of the successes of modern biotechnology. In the
process used to make the majority of clinical-grade human insulin,
pig insulin is transformed into the methyl ester of insulin of human
sequence in a reaction catalysed by trypsin. During the trypsin-
catalysed transformation, the alanyl residue at position B ° of
pig insulin is removed and replaced by a methyl-esterified residue
of threonine (Scheme 1). The presence of the ester function,
necessary if high yields are to be obtained in the transformation,
also permits separation of the product from substrate by ion
exchange chromatography, whereupon semisynthetic human
insulin is generated by saponification of the ester. A key step
in the production process is the trypsin-catalysed transformation.
For this transformation, three extreme mechanistic cases have
been discussed (Rose et al., 1984; and Scheme 1): (i) the reaction
proceeds via formation of an acyl-enzyme intermediate which
is aminolysed by threonine ester to give product without prior
hydrolysis to des-Ala-B30-insulin; (ii) pig insulin is hydrolysed
to des-Ala-B30-insulin, which then undergoes immediate
coupling to give product; (iii) pig insulin, and thereafter
acyl-enzyme intermediate, is hydrolysed reversibly to des-
Ala-B30-insulin, and on average only after many cycles of
acyl-enzyme intermediate — des-Ala-B30-insulin is the acyl-
enzyme intermediate aminolysed to product. These three
mechanisms may be distinguished by measuring the incorporation
of labelled oxygen into product during a reaction carried out in
a medium enriched with a stable isotope of oxygen. Mechanism
(i) would not lead to any incorporation of label. Mechanism (ii)
would lead to a maximum of -50% incorporation of label from
the medium since the labelled oxygen atom incorporated on
hydrolysis is one of two, and one is lost on subsequent product
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formation. Mechanism (iii) would lead to incorporation of label
to an abundance similar to that existing in the medium. (Similar,
but not identical because of kinetic and thermodynamic isotope
effects; these can be very large in the case of isotopes of hydrogen
but are small in the case of isotopes of the much heavier oxygen.)
Two previous studies have addressed this mechanistic question.
The study of Markussen and Schaumburg (1983), using 17O and
NMR spectroscopy, seemed to support mechanism (i) since the
authors reported that no incorporation of label into product
occurred. The study of Rose et al. (1984), using 18O and MS,
supported mechanism (iii), since these authors found that
extensive incorporation of label occurred. However, different
experimental conditions were examined in this latter study [higher
organic solvent concentration, butane-1,4-diol in place of N,N-
dimethylacetamide, H-Thr(f-Bu)-O-f-Bu in place of H-Thr-OMe,
and bovine trypsin in place of porcine trypsin].
In view of the conflicting results of the two studies and of
kinetic evidence throwing doubl on the NMR study (Markussen,
1987), we decided to reinvestigate the transformation which
occurs in aqueous dimethylacetamide with H-Thr-OMe as
nucleophile and porcine trypsin as catalyst, which are the
conditions used industrially.
Materials and methods
Human insulin methyl ester (zinc form), pig insulin (mono-
component grade, zinc form) and crystalline H-Thr-OMe free
base were the products of Novo Industri, Denmark. Porcine
trypsin and 18OH2 (97% atomic abundance, normalized) were
obtained from Sigma Chemical Co. and MSD Isotopes (Montreal)
respectively. Pentadeutero-L-threonine (98% D, unlabile protons)
was obtained from CEA, Gif-sur-Yvette, France, and was
converted into H-[2H5]-Thr-OMe free base by Novo-Nordisk,
Bagsvaerd, Denmark. All other reagents and solvents of analytical
grade, or better, were obtained from commercial sources, and
were used without further purification.
Transformation
The exact conditions of Markussen and Schaumburg (1983) were
used, except that l8O-enriched water replaced the water used in
their experiment. All tubes were kept sealed with several layers
of sealing film, except during addition and removal of contents.
To 10 mg pig insulin (and to 10 mg human insulin methyl ester
in a separate 6 X 30 mm glass tube) was added 50 /d 10 M acetic
acid made by mixing 115 /tl 100% acetic acid with 86 /i\ I8OH2.
To these solutions were added 130 /il of a solution of H-Thr-OMe
(204.8 mg in 1 ml MA'-dimethylacetamide) and the temperature
was lowered to 12°C. Porcine trypsin (3.5 mg) was dissolved
in 50 /il calcium acetate solution [0.69 mg Ca(OAc)2 in 82 /il
18OH2] and kept on ice for 10 min. To both samples 20 /il
trypsin solution was added under vortex mixing and the tubes
were set aside at 12°C. Although perfectly soluble, the contents
were mixed from time to time to ensure homogeneity. Samples
(20 /il) were withdrawn for analysis after 0, 1,2, 4, 8, 16, 24
and 48 h. Time zero was counted as the moment when the trypsin
solution was added, and the first aliquot was withdrawn within
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Hydrolysis
-Lys-OH + trypsin
(DAI)
K+l k +2
-Lys-Ala-OH + trypsin ^=± (-Lys-Ala-OH).trypsin ^=± -Lys-trypsin + H-Ala-OH
k k
-I enzyme-substrate -2 acyl-enzyme intermediate
complex
RNH-,
'•-4
-Lys-NHR + trypsin
Aminolysis
-Lys-Ala-OH = pig insulin
RNH, H-Thr-OMe
30DAI = des-Ala-B-* -insulin
Scheme 1. Partial reaction scheme for the trypsin-catalysed transformation of pig insulin into an ester of insulin of human sequence (modified from Rose el
al., 1984).
2 min of this addition. Immediately upon removal, each aliquot
was treated with 200 /tl acetone to precipitate protein and stop
the reaction. The precipitate was sedimented by centrifugation
and, after removal of the supernatant, was washed by re-
suspension with two more 200 /tl portions of acetone before being
dried under vacuum.
Similar experiments, at reduced scale, were performed using
H-[2H5]-Thr-OMe in place of H-Thr-OMe.
Analysis of coupling yield
Each of the 16 precipitates was dissolved in 200/tl 0.1%
trifluoroacetic acid. A small portion (4 /tl) was removed, diluted
into 100 /tl of the same solvent and a 30 /tl aliquot analysed by
reversed-phase HPLC. HPLC was performed using equipment
from Waters Associates (M6000A and M45 pumps, Wisp 710B
automatic injector, Model 440 absorbance detector and an
extended wavelength module). The column was 250 X 4 mm
diameter packed with Nucleosil C8 5 /tm 300 A particles
(Machery Nagel) and operated at a flow rate of 0.6 ml/min.
Solvent A was 1 g trifluoroacetic acid (Pierce) added to 1 1 water
(MilliQ system). Solvent B was prepared by adding 1 g tri-
fluoroacetic acid to 100 ml water and making up to 1 1 with
acetonitrile (Lichrosolv, Merck). The column was equilibrated
with 30% solvent B prior to sample injection. These conditions
were maintained for 5 min after injection, whereupon a linear
gradient (0.5% B/min) was initiated to 50% B. After 5 min at
50% B, the column was brought back to 30% B over 5 min and
equilibrated for 15 min prior to the next injection. Effluent was
monitored at 214 nm.
Sample preparation for mass spectrometry
Trypsin was removed from samples by HPLC under conditions
used for analysis (see above). For this purpose, 180 /tl of the
remaining 196 /tl of each sample was injected and the broad peak
due to insulin, des-Ala-B30-insulin and human insulin methyl
ester (unseparated from each other at this high loading) was
collected (retention time 27-31 min), well separated from trypsin
(retention time 41—48 min). Solvent was removed in a vaccum
centrifuge (Speedvac, Savant). Samples were resuspended in
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water and redried to remove residual trifluoroacetic acid. Each
sample was then dissolved in 800 /tl ammonium bicarbonate
solution (1 %, w/v). To 400 /tl of each sample was added 9 /tl
of a solution of Staphylococcus aureus V8 protease (1 mg/ml
in water) and the tubes incubated at 37° C for 6 h. After drying
in the vacuum centrifuge, samples were taken up in 10 /tl 0.1 %
trifluoroacetic acid and analysed by fast atom bombardment mass
spectroscopy (FAB/MS). Analysis by FAB/MS in positive ion
mode was performed as previously described (Savoy et al.,
1988a,b). In order to obtain high precision in the measurement
of isotopic abundance, each sample was analysed twice and the
peptide originating from the C-terminal region of the B chain
(H-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr-OMe) was on both
occasions studied by taking 16 spectra over the molecular ion
region and averaging the data.
Results and discussion
The yield of the trypsin-catalysed transformation of pig insulin
into an ester of human insulin is represented graphically as a
function of time in Figure 1. A yield of 93 % is observed after
24 h, and this rises to 94% after a further 24 h. These results
are in good agreement with the yield of 92% after 24 h reported
previously (Markussen and Schaumburg, 1983).
In contrast with that previous study, however, incorporation
of labelled oxygen into the C-terminal region of the B chain
(H-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr-OMe) was found to
be extensive. In a previous similar study, the site of incorporation
was shown to be the B29-B30 peptide bond (Rose et al., 1984),
as expected from Scheme 1. Incorporation of I8O is shown as
a function of time in Figure 2, for both the reaction with pig
insulin as substrate and the control reaction with human insulin
methyl ester as substrate. In the case of pig insulin as substrate,
the relatively small amount of product formed during the first
hour of reaction shows a high degree of incorporation of label,
and this degree of incorporation rises rapidly to reach a plateau
of >85%. The slight fall occurring towards the end of the
experiment may be due to ingress of unlabelled moisture into
the cooled reaction tube during the removal of aliquots.
Semisynthesis of human insulin
-a
time (h)
Fig. 1. Graph showing yield of human insulin methyl ester as a function of time. Reaction conditions are given in Materials and methods.
time (h)
Fig. 2. Graph showing degree of incorporation of I8O into the B29—B30 peptide bond of human insulin methyl ester as a function of time. D , Reaction using
pig insulin as substrate; A, control reaction using human insulin methyl ester as substrate. Standard error of the mean (16 measurements) was < 1% in all
cases.
Human insulin methyl ester, the product of the reaction between
pig insulin and H-Thr-OMe, is itself a substrate for trypsin. Under
the conditions of our experiment, Thr-OMe at the C terminus
of the B chain is continually replaced by Thr-OMe from solution.
Figure 2 shows that, during this process, label is incorporated
into the B29-B30 peptide bond. The initial rate of incorporation
of label in the control experiment (Figure 2) is considerably
slower than both the coupling reaction (Figure 1) and the rate
of incorporation of label into product during the transformation
of pig insulin (Figure 2). We can thus be sure that the
incorporation of label observed during the transformation of pig
insulin is not simply due to incorporation into product once
formed.
None the less, it is possible that, in addition to aminolysis after
incorporation, some aminolysis of human insulin methyl ester
occurs without incorporation of 18O. Such aminolysis without
incorporation of label would be invisible to us, since there would
be no change in HPLC or mass spectrometric properties. To
investigate this possibility we repeated the above experiments
using H-[2H5]-Thr-OMe in place of H-Thr-OMe.
In the case of human insulin methyl ester, aminolysis of this
substrate, initially unlabelled, was visible as a mass increase of
5 atomic mass units where not accompanied by incorporation of
I8O, and as an increase of 7 mass units where incorporation of
I8O occurred. The proportion of mass-shifted material in the
spectrum permitted the total degree of aminolysis to be calculated:
19, 32 and 83% after 1, 2 and 8 h respectively. Comparison with
the data in Figures 1 and 2 shows that the total rate of aminolysis
is comparable with the rate of reaction of pig insulin (Figure 1)
and a little less than twice as fast as the rate of incorporation
of I8O shown in Figure 2. It must not be forgotten that, after
incorporation of an I8O atom by hydrolysis, it has - 5 0 %
probability of being expelled upon peptide bond formation and
so, if direct aminolysis and hydrolysis-coupling (see Scheme 1)
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occurred at equal rates, the initial product distribution would
show only 25% (and not 50%) incorporation of I8O. We may
therefore deduce that aminolysis can and does occur without
incorporation of 18O, although for the majority of molecules
there is incorporation of 18O. This deduction is supported by the
mass spectra obtained in the experiment just described, where
H-[2H5]-Thr-OMe was used in place of H-Thr-OMe. At all time
points (except of course time zero, when there was no product
at all) and for both pig insulin and human insulin methyl ester
as substrate, the signal peak due to product having incorporated
18O (mass shifted by 7 mass units due to the five deuterium
atoms and one 18O atom) was more intense (by a factor of
between 1.03 and 2.6, depending on substrate and time point)
than that due to product not having incorporated 18O (and
therefore mass shifted by only 5 mass units due to the five
deuterium atoms).
Conclusions
The present study shows that, during the trypsin-catalysed
transformation of pig insulin into an ester of insulin of human
sequence, labelled oxygen is rapidly incorporated from the
medium into the B - B 3 0 peptide bond. None the less,
aminolysis of the acyl enzyme intermediate may occur without
hydrolysis for a small proportion of molecules. For the
majority, mechanism (iii) is followed whereby pig insulin, and
thereafter acyl-enzyme intermediate, is hydrolysed reversibly to
des-Ala-B30-insulin, and on average only after several cycles
of acyl-enzyme intermediate — des-Ala-B30-insulin is the
acyl-enzyme intermediate aminolysed to product. A better
understanding of reverse proteolysis should permit further
progress in the field of enzymic activation of polypeptide chains
(Rose et al., 1988, 1989; Proudfoot et al., 1989).
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